Beaten-Down Cannabis Stocks Are Showing Signs of Life

America just waved a white flag in its war on drugs. And it could kick off a major investment opportunity... [Stansberry Research Logo] Delivering World-Class Financial Research Since 1999 [DailyWealth] Beaten-Down Cannabis Stocks Are Showing Signs of Life By Sean Michael Cummings, analyst, True Wealth --------------------------------------------------------------- America just waved a white flag in its war on drugs... Last week, the U.S. Department of Health and Human Services ("HHS") advised the Drug Enforcement Administration ("DEA") to ease its policy on weed. The recommendation was to move marijuana to Schedule III status... Currently, cannabis is a Schedule I controlled substance. Schedule I substances include heroin and LSD, and they come with the harshest punishments for possession. According to the DEA, Schedule III drugs "have a potential for abuse less than substances in Schedules I or II." Other Schedule III substances include anabolic steroids and cough syrup. This is a significant shift in posture. And it could kick off a major investment opportunity... --------------------------------------------------------------- Recommended Links: ['If You Missed the Bottom in 2020... Wake Up!']( The man who handed our firm two 10-baggers says: "The time to buy is NOW. Buy into this rare investment as soon as possible – at a HISTORICALLY LOW PRICE YOU MAY NEVER SEE AGAIN." [Click here for the details (ticker included)](. --------------------------------------------------------------- [His System Isolated Nvidia – Here's His NEXT Buy]( Marc Chaikin's stock-picking system isolated Nvidia before its massive bull run this year. Now, his system just flashed "BUY" on a new artificial-intelligence company that no one is talking about yet. It's not a household name, but Marc predicts it could quickly double or triple from here. [Click here for the name and ticker](. --------------------------------------------------------------- Since 2021, cannabis stocks have been a classic investing "value trap." We can see it with Canopy Growth (CGC), a publicly traded weed company that acts as a bellwether for this sector. The stock has fallen further and further for more than two years straight. CGC is down almost 100% from its February 2021 peak. The stock just keeps getting cheaper. But if you tried to call the bottom at any point in the past two years, you almost certainly lost money. However, the recent HHS recommendation breathed new life into this beaten-down sector. Weed stocks have spiked since the recommendation. And this spike pushed CGC's price past a key level... the 50-day moving average (50-DMA). The 50-DMA is exactly what it sounds like. It's an average of the last 50 days of CGC's prices. But it also acts as an important level of psychological "resistance." In other words, traders think the 50-DMA level is a fair value for the stock, so they'll often step in to sell when the price crosses this level. Because of this tendency, we want to pay special attention when a stock breaches its 50-DMA. And that's just what happened for CGC last week. Take a look... CGC is trading above its 50-DMA for the first time since February. I wanted to see what happened when CGC broke its 50-DMA in the past. So I found the forward returns after days when the price overtook this resistance level. Since CGC went public in 2014 (under the name Tweed), there have only been 75 days when the stock price pierced its 50-DMA on the way up. So it's a fairly rare signal. But it points to major outperformance for the cannabis bellwether. Take a look... As I mentioned above, CGC has been stuck in a grinding, multiyear bear market. In an average year, the stock lost about 17% of investors' cash. But buying when CGC breached its 50-DMA led to dramatic outperformance... Historically the stock dipped about 3% in the first three months after this signal. But then it cruised to some serious gains. It returned an average of 16% in the six-month period... and 34% in a year. Now, this is a volatile signal. The largest return in a one-year period was a staggering 455%... But the worst one-year return slashed investors' cash by 87%. If you do trade this signal, though, the odds are on your side. After cases where CGC breached its 50-DMA, the stock was up one year later 74% of the time. So your chances of outperforming are roughly 3 out of 4. Just remember, CGC has been a historically risky investment. So keep your position size reasonable... and as always, use a stop loss. Cannabis stocks have been caught in a grinding downturn. But history says buying after breakouts like today's can lead to outperformance – and we may be in the first stages of a big rally for this sector. Good investing, Sean Michael Cummings Further Reading One major trend has grabbed headlines this year and sent a few key stocks soaring: the rise of AI. This technological sea change is just beginning. Here are three ways we'll likely see companies get in on the boom... [Read more here](. "You will take some losses from time to time," Chris Igou writes. "But by cutting them short, you live to trade another day." This is especially crucial to remember when you're looking at a speculative opportunity. A few key steps can help you minimize your risk in the markets... [Learn more here](. Market Notes HIGHS AND LOWS NEW HIGHS OF NOTE LAST WEEK Alphabet (GOOGL)... tech "World Dominator" Nvidia (NVDA)... chip giant Cisco Systems (CSCO)... Internet "plumber" Adobe (ADBE)... cloud services Workday (WDAY)... cloud-based software Splunk (SPLK)... cybersecurity Intuit (INTU)... tax-prep software Visa (V)... payment-processing giant Brown & Brown (BRO)... insurance Walmart (WMT)... "World Dominator" of discount retail Ollie's Bargain Outlet (OLLI)... discount retailer Sprouts Farmers Market (SFM)... grocery stores Yeti (YETI)... outdoor products Targa Resources (TRGP)... natural gas Cameco (CCJ)... uranium NEW LOWS OF NOTE LAST WEEK Chewy (CHWY)... pet products JetBlue Airways (JBLU)... airline --------------------------------------------------------------- [Tell us what you think of this content]( [We value our subscribers' feedback. To help us improve your experience, we'd like to ask you a couple brief questions.]( [Click here to rate this e-mail]( You have received this e-mail as part of your subscription to DailyWealth. If you no longer want to receive e-mails from DailyWealth [click here](. Published by Stansberry Research. You're receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized investment advice. © 2023 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or [www.stansberryresearch.com](. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors. Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.